These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 3183955

  • 1. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [Abstract] [Full Text] [Related]

  • 2. Effects of an alkylating derivative of oxotremorine (BM 123A) on heart rate, muscarinic receptors and adenylate cyclase activity in the rabbit myocardium.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):804-11. PubMed ID: 3598904
    [Abstract] [Full Text] [Related]

  • 3. Coupling of muscarinic receptors to adenylate cyclase in the rabbit myocardium: effects of receptor inactivation.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):23-30. PubMed ID: 3806386
    [Abstract] [Full Text] [Related]

  • 4. Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations.
    Ehlert FJ, Rathbun BE.
    Mol Pharmacol; 1990 Jul; 38(1):148-58. PubMed ID: 2370853
    [Abstract] [Full Text] [Related]

  • 5. The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium.
    Ehlert FJ.
    Mol Pharmacol; 1985 Nov; 28(5):410-21. PubMed ID: 4058422
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T, Boselli C.
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [Abstract] [Full Text] [Related]

  • 7. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ, Jenden DJ.
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [Abstract] [Full Text] [Related]

  • 8. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 9. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ, Delen FM, Yun SH, Friedman DJ, Self DW.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [Abstract] [Full Text] [Related]

  • 10. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 11. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.
    Baumgold J, Drobnick A.
    Mol Pharmacol; 1989 Sep; 36(3):465-70. PubMed ID: 2550780
    [Abstract] [Full Text] [Related]

  • 12. Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
    Griffin MT, Ehlert FJ.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):221-5. PubMed ID: 1328607
    [Abstract] [Full Text] [Related]

  • 13. Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase.
    Gerstin EH, Luong T, Ehlert FJ.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):910-7. PubMed ID: 1281880
    [Abstract] [Full Text] [Related]

  • 14. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 15. Muscarinic cholinergic receptor-mediated attenuation of adenylate cyclase activity in rat heart membranes.
    Smith MM, Harden TK.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Oct; 10(2):197-210. PubMed ID: 3998232
    [Abstract] [Full Text] [Related]

  • 16. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [Abstract] [Full Text] [Related]

  • 17. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
    Waelbroeck M, Robberecht P, De Neef P, Christophe J.
    J Recept Res; 1988 Mar; 8(6):787-808. PubMed ID: 3193402
    [Abstract] [Full Text] [Related]

  • 18. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA, Miller RC, Eck M, Paquet JL.
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [Abstract] [Full Text] [Related]

  • 19. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA, Hsu HH, Griffin MT, Hunter AL, Luong T, Ehlert FJ.
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J, Brown JH.
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.